Mead Johnson Is Mead Johnson the concern? It is 36% of revenue so
if they have an alternative DHA product watch out
below. Business & Finance > Investments > Stocks (A to Z) > Stocks M > Martek Biosciences Corp. (MATK)
Re: MA IS GOING DOWN, HA..... Try a p/e of 20. No wonder you are losing so much money
on this investment. You don't even know how to
analayse it. Business & Finance > Investments > Stocks (A to Z) > Stocks M > Mastercard Incorporated (MA)
Re: SAD? ITS A STINKING DISASTER Wrong. It is going down because inventories are growing
much faster than revenues again. You can't just
look at EBITDA. A biopharmaceutical with a basic
monopoly... Business & Finance > Investments > Stocks (A to Z) > Stocks M > Martek Biosciences Corp. (MATK)
Red Flag There is a red flag when resaerching companies that
states when inventories grow faster than revenues
look out below. This has happened a... Business & Finance > Investments > Stocks (A to Z) > Stocks M > Martek Biosciences Corp. (MATK)
Re: NASDAQ Listing Saved From the press release: Finally, the Company has authorized
a share repurchase program of up to 1 million shares.
My mistake. A 1 million share buyback and not a $1
million buyback. It is pretty much... Business & Finance > Investments > Stocks (A to Z) > Stocks P > Premier Exhibitions Inc. (PRXI)
Re: NASDAQ Listing Saved The only reason they were able to keep it above $1
is because of the $1 million buyback. Hopefully it
doesn't sink once the buyback is finished. Business & Finance > Investments > Stocks (A to Z) > Stocks P > Premier Exhibitions Inc. (PRXI)
Buyout (What happened?) Whatever happened with this buyout of Sellers shares
for $3.00? I think it was a fake offer just so there
would be a lot of volume so that the old CEO could
sell some... Business & Finance > Investments > Stocks (A to Z) > Stocks P > Premier Exhibitions Inc. (PRXI)
Re: Unreal The PBS story might be 5% of the reason the stock is
going up. The other 95% is because of the recent BSX
study and this quote: The findings presented in the
article... Business & Finance > Investments > Stocks (A to Z) > Stocks A > Angiotech Pharmaceuticals, Inc.
Read this quote from BSX The findings presented in the article are consistent
with our own clinical trial observations, including
recently published ARRIVE and ATLAS data... Business & Finance > Investments > Stocks (A to Z) > Stocks A > Angiotech Pharmaceuticals, Inc.
g michaelharris You probably can't answer this question but if
you are willing to pay $3 a share to Sellers you believe
the company is worth more than $3 a share. Why don't
you offer between $1.85 and $2.50 for the... Business & Finance > Investments > Stocks (A to Z) > Stocks P > Premier Exhibitions Inc. (PRXI)
Not buying Premier They are not buying Premier. This deal revolves around
the Titanic assets. This is precisesly why Sellers
(directors) is able to sell their... Business & Finance > Investments > Stocks (A to Z) > Stocks P > Premier Exhibitions Inc. (PRXI)
Sold back in the low 50&&39;s Haven't been on this message board in quite awhile
because I have been out of the stock so long. Of course
I think it is very attractive again trading right
at book value with over $6 in free cash flow... Business & Finance > Investments > Stocks (A to Z) > Stocks M > Martek Biosciences Corp. (MATK)
What a joke No question and answer on the earnings call because
Arnie knows his days are numbered. He might say he
will do anything to save this company but face it
he isn't management material. He... Business & Finance > Investments > Stocks (A to Z) > Stocks P > Premier Exhibitions Inc. (PRXI)
Management is awful Please, please make sure you vote with the Sellers
group. This management is awful. Just spend an hour
or two and research this comapny over the last two
years. This is not a management that... Business & Finance > Investments > Stocks (A to Z) > Stocks P > Premier Exhibitions Inc. (PRXI)
Positive news coming There must be some good news coming because insiders
are buying. I doubt they want to lose all this money
they are spending. Business & Finance > Investments > Stocks (A to Z) > Stocks A > Angiotech Pharmaceuticals, Inc.
Ridiculous analysis by JP Morgan Where is the premium? I would much rather look at where
JNJ should trade. The average p/e over the last 10
years is 25 and the last 5 years is 19.4. The average
p/e for... Business & Finance > Investments > Stocks (A to Z) > Stocks J > Johnson & Johnson (JNJ)
Re: Relative to PRXI... I think intrinsic value of $6-$7 might be a little
more realistic. Another good risk/reward stock is
Angiotech (ANPI). Business & Finance > Investments > Stocks (A to Z) > Stocks P > Premier Exhibitions Inc. (PRXI)
